Scientists at Fred Hutchinson Cancer Research Center took a step toward making gene therapy more practical by simplifying the way gene-editing instructions are delivered to cells. Using a gold nanoparticle instead of an inactivated virus, they safely delivered gene-editing tools in lab models of HIV and inherited blood disorders, as reported May 27 in Nature Materials.
Right fielder honored for overcoming personal tragedy, demonstrating a commitment to scientific research and exemplifying the spirit of Fred Hutchinson
Below are summaries of recent Fred Hutch research, with links for additional background and media contacts.
Below are summaries of recent Fred Hutch research, with links for additional background and media contacts.
Fred Hutchinson Cancer Research Center’s latest findings in immunotherapies, nanoparticles to deliver gene therapy, the genetic underpinnings of cancer, insights on health disparities and more will be showcased at the annual meeting of the American Association for Cancer Research. The conference, “Integrative Cancer Science — Global Impact — Individualized Patient Care,” will be held March 29–April 3 in Atlanta.
Summaries of recent Fred Hutch research, with links for additional background and media contacts.
Fred Hutchinson Cancer Research Center has announced the 2019 recipients of the annual Harold M. Weintraub Graduate Student Award, which recognizes outstanding achievement in graduate studies in the biological sciences.
The first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk published today in the New England Journal of Medicine. The study found no significant reduction in venous thromboembolism or death in the overall 180-day trial period; however, the researchers did observe a lower incidence of these events while patients were actively on the study drug, or during the on-treatment period.
Findings in Journal of the National Cancer Institute shows patients don’t have enough opportunities for participation
Summaries of recent Fred Hutch research.
Summaries of recent Fred Hutch research, with links for additional background and media contacts.
Summaries of this year’s notable advances at Fred Hutchinson Cancer Research Center and beyond.
Summaries of recent Fred Hutch research with links for additional background and media contacts.
Large-scale genomic study discovers 40 new genetic variants associated with colorectal cancer risk
Fred Hutchinson Cancer Research Center’s latest findings on cancer immunotherapies, CRISPR for blood disorders, stem cell transplantation and insights on the immune system and cancer will be featured at the 60th annual meeting of the American Society of Hematology, which will be held Dec. 1–4 in San Diego.
Study confirms biological mechanism responsible for latent HIV reservoirs; suggests strategies for a functional HIV cure
This month's Fred Hutch tip sheet includes story ideas about understanding how skin stops tumor growth, advances in studying Kasposi sarcoma, and forecasting the flu. To pursue any of these stories ideas, contact the person listed.
Fred Hutch is committed to better understanding prostate cancer, creating new treatment therapies and technologies and ultimately, finding a cure. This tip sheet includes brief summaries of the work our researchers are doing around prostate cancer and some high-level points to be aware of.
This month's tip sheet from Fred Hutch highlights research related to cancer-causing bacteria, a cancer 'escape hatch,' how sex cells sort chromosomes, cord blood's role in leukemia treatment and more.
Fred Hutchinson Cancer Research Center is committed to reducing breast cancer incidence and death by identifying risk factors for the disease, developing new methods of detecting it and helping to predict health outcomes based on a woman’s genetics and other factors. This tip sheet includes brief summaries of the work our researchers are doing around breast cancer and some high-level points to be aware of in anticipation of Breast Cancer Awareness Month in October.
Harnessing the immune system to treat cancer shows great promise in some patients, but for many, the response does not last long-term. In an effort to find out why, Fred Hutchinson Cancer Research Center scientists are using a new technology to look at how cancer cells change under the pressure of immunotherapy treatments.
The August tip sheet from Fred Hutch includes story ideas about next-gen CAR T-cell immunotherapies, cancer care disparities in rural and urban settings, organizing chromosomes in egg and sperm cells, decoding our immune system's memories and more.
CAR T-cell therapy, which reprograms immune cells to fight cancer, has shown great promise in people with some blood cancers who have not responded to other treatments. But until now, the underlying biological pathways enabling anti-cancer responses have not been thoroughly examined.
When enrolled in a cancer clinical trial, the differences in survival rates between rural and urban patients are significantly reduced, SWOG study results show.
Fred Hutchinson Cancer Research Center announced it received a five year Science Education Partnership Award (SEPA) from The National Institute of General Medical Sciences (NIGMS), worth $1.26 million.
This month's medical tip sheet from Fred Hutchinson Cancer Research Center includes stories about acupuncture for breast cancer patients, nanoparticles that pave the way for CAR T-cell immunotherapy in solid tumors and the link between childhood abuse and endometriosis later on in life. Also included is information on several awards and recognitions.
A study of more than 60,000 women has found that sexual and physical abuse in childhood and adolescence is associated with a greater risk of laparoscopically-confirmed endometriosis diagnosed during adulthood. The study – the largest of its kind – found that women reporting severe-chronic abuse of multiple types had a 79 percent higher risk of laparoscopically-confirmed endometriosis.
This month's tip sheet from Fred Hutch includes story ideas about immunotherapy for a deadly type of skin cancer, cancer care that costs twice as much but yields no better outcome, yoga and music therapies for breast cancer and more. To pursue any of these story ideas, please contact the individual listed for each.
A breast cancer patient dealing with anxiety, depression or mood swings could soon be encouraged by her oncologist to learn meditation techniques, join a yoga class or put music to therapeutic use. Today, the American Society of Clinical Oncology (ASCO), published its endorsement of integrative therapy guidelines recently established by the Society for Integrative Oncology (SIO).
Fred Hutchinson Cancer Research Center announced the election of a new board of trustees chair, a new vice chair and two new members. Each brings additional expertise in finance, technology, bioscience and data science as the Hutch accelerates efforts to develop cures for cancer and other diseases.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right